Intel Corp Files 8-K for Material Definitive Agreement

TL;DR

Intel signed a big deal, filing an 8-K. Details to follow.

AI Summary

On April 11, 2025, Intel Corporation entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and headquartered in Santa Clara, California.

Why It Matters

This filing indicates a significant new agreement for Intel, which could impact its business operations, financial performance, and strategic direction.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.

Key Numbers

• 000-06217 — SEC File Number (Identifies Intel's filings with the SEC.)
• 94-1672743 — IRS Employer Identification No. (Intel's tax identification number.)

Key Players & Entities

• Intel Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• Santa Clara, California (location) — Principal executive offices
• April 11, 2025 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common stock, $0.001 par value INTC Nasdaq Global Select Mar

Filing Documents

• intc-20250411.htm (8-K) — 35KB
• ex101-gryphonxtransactiona.htm (EX-10.1) — 52KB
• intc-20250411_g1.jpg (GRAPHIC) — 5KB
• 0000050863-25-000123.txt ( ) — 223KB
• intc-20250411.xsd (EX-101.SCH) — 2KB
• intc-20250411_lab.xml (EX-101.LAB) — 21KB
• intc-20250411_pre.xml (EX-101.PRE) — 12KB
• intc-20250411_htm.xml (XML) — 3KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on April 14, 2025, Intel Corporation ("Intel"), Intel Americas, Inc., Altera Corporation, (the "Company"), and SLP VII Gryphon Aggregator, L.P. (the "Purchaser") (collectively, the "Parties"), entered into a transaction agreement (the "Transaction Agreement") pursuant to which Intel agreed to sell a majority interest in its Altera business operated by the Company to the Purchaser (the "Transaction"). On August 11, 2025, the Parties entered into Amendment No. 1 to the Transaction Agreement ("Amendment No. 1"), which, among other things, amended the following aspects of the Transaction Agreement: Purchase Price Calculations : Amendment No. 1 includes various technical changes to the purchase price calculation definitions, which changes are not expected to materially impact the net cash proceeds to Intel from the transaction. Closing Date : Amendment No. 1 also provides that the closing of the transaction contemplated by the Transaction Agreement (the "Closing") shall not occur prior to September 12, 2025, without the prior written consent of each of the Parties, and extends the initial date by which the Closing must occur from August 12, 2025, to September 13, 2025.

Forward-Looking Statements

Forward-Looking Statements This report contains forward-looking statements as to Intel's expectations regarding Amendment No. 1, including the expected impacts of the changes to the purchase price calculation. Such statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including: the risk that the Transaction may not be completed in a timely manner or at all, including as a result of a failure to receive regulatory approvals; the occurrence of any event, change or other circumstance that could give rise to the termination of the Transaction; the risk that the expected benefits of the Transaction, including as a result of the increased independence of the Altera business, may not be realized; the risk of future loss of business with the Altera business by Intel as a result of the sale of a controlling interest in the Altera business; disputes or potential litigation related to the Transaction or the ownership, control and operation of the Altera business, including as it relates to Intel; unanticipated costs related to the Transaction or the Altera business that may be incurred; risks as to the retention of key personnel and customers of the Altera business; risks related to the diversion of management's attention during the pendency of the Transaction; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; changes in demand for the Altera business' semiconductor products; the high level of competition and rapid technological change in the semiconductor industry; and other risks and uncertainties described in Intel's 2024 Form 10-K, Q1 2025 Form 10-Q, Q2 2025 Form 10-Q and other filings with the SEC. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Readers are urged to carefully review and consider the various disclosures made in

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are provided as part of this report: Exhibit Number Description 10.1 Amendment No. 1 to Transaction Agreement, dated August 11, by and among Intel Corporation, Intel Americas, Inc., Altera Corporation, and SLP VII Gryphon Aggregator, L.P. 104 Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INTEL CORPORATION (Registrant) Date: August 14, 2025 By: /s/ April Miller Boise April Miller Boise Executive Vice President and Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR